Precision BioSciences, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 307.8K | $1.69M | 0.00% | Added+120.6% | 2026-03-31 |
| RenTech | quant | 223.2K | $1.23M | 0.00% | Trimmed-31.6% | 2026-03-31 |
| StateStreet | passive | 72.9K | $401.18K | 0.00% | Added+23.5% | 2026-03-31 |
| Citadel | multi-strat | 35.6K | $195.76K | 0.00% | Added+20.2% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.60 | — | — |
| 2026-05-05 | -0.81 | -0.75 | +7.41% |
| 2026-03-12 | -0.64 | 1.01 | +256.36% |
| 2025-11-03 | -2.21 | -1.84 | +16.74% |
| 2025-08-07 | -2.20 | -2.13 | +3.40% |
| 2025-05-15 | -2.42 | -2.21 | +8.68% |
| 2025-03-26 | -2.94 | -2.14 | +27.47% |
| 2024-11-04 | -3.13 | -2.25 | +28.12% |
| 2024-08-01 | -5.07 | 4.67 | +192.11% |
| 2024-05-13 | -1.91 | 1.70 | +188.85% |
| 2024-03-27 | -2.03 | -15.56 | -666.50% |
| 2023-11-07 | -5.00 | -2.10 | +58.00% |
| 2023-08-04 | -7.50 | -3.00 | +60.00% |
| 2023-05-09 | -6.60 | -6.55 | +0.82% |
| 2023-03-09 | -5.88 | -2.79 | +52.60% |
| 2022-11-08 | -11.16 | -6.60 | +40.86% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DTIL | -4.26% | +60.23% | +67.55% | +44.31% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -7.23% | +64.87% | +70.99% | +31.62% |